Shingo Hatakeyama

Endothelial Heparan Sulfate Controls Chemokine Presentation in Recruitment of Lymphocytes and Dendritic Cells to Lymph Nodes

Xingfeng Bao, E. Ashley Moseman, Hideo Saitô et al. · Immunity · 2010 · 164 citations · Full text

Life Sciences, Cell Biology, Immunology +14

A novel strategy for evasion of NK cell immunity by tumours expressing core2 O‐glycans

Shigeru Tsuboi, Mihoko Sutoh, Shingo Hatakeyama et al. · The EMBO Journal · 2011 · 162 citations · Full text

Life Sciences, Immunology, Oncology +16

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study

Robert J. Motzer, Camillo Porta, Masatoshi Eto et al. · Journal of Clinical Oncology · 2024 · 158 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Tumor suppressor function of laminin-binding α-dystroglycan requires a distinct β3- <i>N</i> -acetylglucosaminyltransferase

Xingfeng Bao, Motohiro Kobayashi, Shingo Hatakeyama et al. · Proceedings of the National Academy of Sciences · 2009 · 122 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptide

Shingo Hatakeyama, Kazuhiro Sugihara, Toshiaki Shibata et al. · Proceedings of the National Academy of Sciences · 2011 · 96 citations · Full text

Pharmacy, Oncology, Pharmacology +17